Gastroparesis Registry 4

Part of paid clinical trials in Scottsdale, Arizona.

Sponsor
Johns Hopkins Bloomberg School of Public Health
Study ID
NCT05846802
Status
Recruiting
Apply to this trial

Conditions

  • Functional Disorder of Gastrointestinal Tract
  • Gastro-Intestinal Disorder
  • Gastroparesis
  • Gastroparesis Due to Diabetes Mellitus Type I
  • Gastroparesis Due to Diabetes Mellitus Type II
  • Gastroparesis Nondiabetic

Eligibility Criteria

Sex
ALL
Age
18 Years - 85 Years
Healthy Volunteers
Not accepted

Study Details

The Gastroparesis Registry 4 (GpR4) is an observational study of patients with symptoms of gastroparesis (Gp) and functional dyspepsia (FD) with either delayed or normal gastric emptying. To better understand these disorders, this registry will capture demographic, clinical, physiological, questionnaire, and patient outcome data to characterize the patients and their clinical course. Participants will complete several questionnaires, complete a nutrient drink test and have a gastric emptying study.

Key Dates

Start date
Sep 20, 2024
Status verified
Mar 2026
Primary completion
Apr 30, 2027
Completion
Apr 30, 2027

Study Design

Enrollment
250 participants (estimated)

Arms

  • Arm: Gastroparesis
    Gastroparesis symptoms with delayed emptying
  • Arm: Functional Dyspepsia
    Gastroparesis symptoms without delayed emptying

Primary Outcome Measure

Measure of symptom severity of gastroparesis and functional dyspepsia using the change in total score from the Patient Assessment of Upper Gastrointestinal Disorders Symptoms (PAGI SYM) from baseline to 48 weeks. [ Time Frame: 48 weeks ]

Central Contacts

Locations (6)

FacilityCityStateZIPSite coordinators
Jay PasrichaScottsdaleArizona85259
Jay Pasricha, MD
[email protected]
Guillermo Barahona
[email protected]
Jay Pasricha, MD (PRINCIPAL_INVESTIGATOR)
University of LouisvilleLouisvilleKentucky40202
Thomas Abell, MD
[email protected]
502-852-7963
Bridget Cannon
[email protected]
(502) 540-1428
Thomas L Abell, MD (PRINCIPAL_INVESTIGATOR)
Massachusetts General HospitalBostonMassachusetts02114
Helen B Murray, PhD
[email protected]
617-726-8470
Madison Paylor
[email protected]
(410)916-9307
Braden Kuo, MD (PRINCIPAL_INVESTIGATOR)
Nir Bar, MD (PRINCIPAL_INVESTIGATOR)
Wake Forest University and Atrium Health Carolinas Medical CenterCharlotteNorth Carolina28202
Baha Moshiree, MD
704-355-4593
Kelsey Cuzzupe
[email protected]
704-355-4593
Baha Moshiree, MD (PRINCIPAL_INVESTIGATOR)
Temple University HospitalPhiladelphiaPennsylvania19140
Henry Parkman, MD
[email protected]
215-707-7579
Rona T Cooper
[email protected]
2157075477
Henry Parkman, MD (PRINCIPAL_INVESTIGATOR)
Texas Tech University Health Science Center (TTUHSC)El PasoTexas79905
Irene Sarosiek, MD
[email protected]
915-545-6626
Denise Vasquez
[email protected]
(915) 214-4388
Irene Sarosiek (PRINCIPAL_INVESTIGATOR)

Find similar trials in Scottsdale, AZ

By research site
Jay Pasricha· Scottsdale, AZUniversity of Louisville· Louisville, KYMassachusetts General Hospital· Boston, MAWake Forest University and Atrium Health Carolinas Medical Center· Charlotte, NCTemple University Hospital· Philadelphia, PATexas Tech University Health Science Center (TTUHSC)· El Paso, TX

Related Studies